We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
55 hedge funds and large institutions have $90.7M invested in Amphastar Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
240% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 5
100% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 10
22% more funds holding
Funds holding: 45 → 55 (+10)
8% more capital invested
Capital invested by funds: $84.4M → $90.7M (+$6.33M)
Holders
55
Holders Change
+10
Holders Change %
+22.22%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
20
Reduced
10
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.98M |
| 2 |
KCM
Kingdon Capital Management
New York
|
+$2.13M |
| 3 |
BC
Broadfin Capital
New York
|
+$1.63M |
| 4 |
FCE
Fiera Capital (Europe)
Grand Cayman,
Cayman Islands
|
+$1.32M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.16M |
